logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > 4-Amino-3-phenylbutanoic Acid CAS 1078-21-3

4-Amino-3-phenylbutanoic Acid CAS 1078-21-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1078-21-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1078-21-3
Appearance::
White Solid
Molecular Formula::
C10H14ClNO2
Molecular Weight::
215.67700
EINECS NO::
214-079-6
MDL NO::
MFCD00075860
CAS NO::
1078-21-3
Appearance::
White Solid
Molecular Formula::
C10H14ClNO2
Molecular Weight::
215.67700
EINECS NO::
214-079-6
MDL NO::
MFCD00075860
4-Amino-3-phenylbutanoic Acid CAS 1078-21-3

Product Description:

Product Name: 4-Amino-3-phenylbutanoic acid CAS NO: 1078-21-3

 

 

Synonyms:

fenigam;

Benzenepropanoic acid, β-(aminomethyl)-;

phenigam;

 

 

Chemical & Physical Properties:

Appearance: White solid

Assay :≥99.0%

Density: 1.1248 (rough estimate)

Melting Point: 194.0-202.0℃

Boiling Point: 311.75℃ (rough estimate)

RefractiveIndex: 1.5710 (estimate)

 

 

Safety Information:

HS Code: 2922499990

Hazard Code: Xi

 

 

Phenibut (fenibut, phenybut; brand names Noofen and Citrocard), contracted from β-phenyl-γ-aminobutyric acid (β-phenyl-GABA), is a central depressant and analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA), or a GABA analogue. The addition of a phenyl ring allows phenibut to cross the blood–brain barrier. Phenibut was developed in the Soviet Union in the 1960s, and has since been used there as a pharmaceutical drug to treat a wide range of ailments, including posttraumatic stress disorder, anxiety, depression, asthenia, insomnia, alcoholism, stuttering, and vestibular disorders, among other conditions. In some other parts of the world, phenibut is not approved for clinical use, and is instead sold as a nutritional supplement. It has been reported by some researchers to possess nootropic actions for its ability to improve neurological functions,[medical citation needed] but others have not observed these effects. It is generally accepted that phenibut has anxiolytic effects in both animal models and in humans.

Phenibut is a close structural analogue of GABA, as well as of baclofen (β-(4-chlorophenyl)-GABA), pregabalin (β-isobutyl-GABA), and GABOB (β-hydroxy-GABA). Originally thought to act as a selective GABAB receptor agonist, phenibut has since been found to act preferentially as a blocker of α2δ subunit-containing voltage-gated calcium channels, similarly to gabapentin and pregabalin. As such, by definition, phenibut is a gabapentinoid.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.